Wahab Adebisi

At Apellis Pharmaceuticals, now part of Biogen, I lead safety surveillance, risk assessments, and safety management for assigned products, supporting clinical safety strategy, risk management plans, regulatory reports, and Health Authority interactions.

Previously at Takeda, Supernus Pharmaceuticals, and US WorldMeds, I led signal detection, safety evaluations, adverse-event review, aggregate safety reporting, and cross-functional safety decision-making across development and marketed products. I've spent more than 10 years helping teams identify, assess, communicate, and manage patient safety risks while maintaining global pharmacovigilance compliance.